Protein C News and Research

RSS

Small tweak to mammal's DNA can cause significant physical changes, study finds

The difference between webbed toes and distinct digits may be the result of not just genetic information, but of how the genes regulate that information. Researchers at the National Institute of Genetics, Research Organization of Information and Systems in Japan found that a small, non-specific tweak to a mammal's DNA can potentially cause specific and significant physical changes.

27 Jan 2018

Researchers uncover key protein that rescues progression of adult spinocerebellar ataxia

Spinocerebellar ataxia is a group of neurodegenerative diseases characterized by progressive incoordination of gait, and is often associated with poor coordination of hands, speech, and eye movements.

27 Jan 2018

Sugar-attaching enzyme found to be abundant in colon cancer cells

Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry.

27 Jan 2018

Researchers working to fill knowledge gap between DNA damage and cancer

Researchers at The University of Kansas Cancer Center are working to fill the knowledge gap between DNA damage and cancer, including developing approaches to manipulate the DNA damage response to treat and prevent disease.

27 Jan 2018

Study sheds light on key protein involved in memory formation and brain growth

Ask a nonscientist what memories are made of and you'll likely conjure images of childhood birthday parties or wedding days. Charles Hoeffer thinks about proteins.

27 Jan 2018

Researchers discover new source of botulinum neurotoxin

A new source of the botulinum neurotoxin was discovered by Canadian and American scientists in a strain of animal gut bacteria known as Enterococcus faecium.

27 Jan 2018

Scientists use synthetic protein to disrupt bacteria’s ability to perform basic life functions

A synthetic protein that disrupts the ability of bacteria to perform basic life functions - moving, eating, attaching to hosts - could be a key to fighting infectious disease and preventing bacteria from evolving into drug-resistant pathogens.

27 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

HORIBA Medical’s latest POC CRP analyzer installed at Thame and Marlow Community Hubs

HORIBA UK Ltd, Medical announces that Thame and Marlow Community Hubs, within Buckinghamshire Healthcare NHS Trust, have each recently installed HORIBA Medical’s latest point-of-care testing analyser, the Microsemi CRP.

From HORIBA Medical 27 Jan 2018

Researchers identify potential enzyme as therapeutic target for type 2 diabetes

Abnormalities in glucose uptake by the liver (or hepatic glucose uptake; HGU) cause elevations in blood glucose levels following meals, a state that is known as postprandial hyperglycemia.

27 Jan 2018

Laser pointer exposure causes eye injuries

In recent years, a substantial increase in the number of eye injuries caused by laser pointers has been observed, especially in children and adolescents.

26 Jan 2018

Scientists discover promising new target to fight a class of viruses

Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.

25 Jan 2018

Researchers identify promising new drug target for Ewing sarcoma

Screening a class of recently-developed drug compounds -- so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins -- against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.

25 Jan 2018

Phototherapeutic technology shows potential as anti-cancer weapon

A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy - which is limited to the skin and areas accessible with an endoscope - this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.

25 Jan 2018